Pentoxifylline therapy may be efficacious in improving the walking capacity of patients with moderate intermittent claudication. However, properly conducted clinical trials are required to provide a true estimate of the benefit.
Philipp K. Haber, Marc Puigvehí, Florian Castet, Vennis Lourdusamy, Robert Montal, Parissa Tabrizian, Michael Buckstein, Edward Kim, Augusto Villanueva, Myron Schwartz, Josep M. Llovet
Witold N. Nowak, Piotr Mika, Roman Nowobilski, Katarzyna Kusińska, Karolina Bukowska-Straková, Rafał Niżankowski, Alicja Józkowicz, Andrzej Szczeklik, Jozef Dulak
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.